Results 1 to 10 of about 6,963 (215)

The effectiveness of erysipelas prophylaxis depends on the cumulative dose of benzathine penicillin G [PDF]

open access: yesDermatology Reports, 2022
Background: Erysipelas is an acute infection due to S. pyogenes and is characterized by a high risk of relapses. The number of patients suffering from one or more recurrences varied depending on the study and accounted for between 16% and 47% of the ...
Agnieszka Bednarska   +8 more
doaj   +2 more sources

Quality of benzathine penicillin G: A multinational cross‐sectional study [PDF]

open access: yesPharmacology Research & Perspectives, 2020
Benzathine penicillin G (BPG) is used as first‐line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD).
Robert M. Hand   +12 more
doaj   +2 more sources

Availability of benzathine penicillin G for syphilis treatment in Shandong Province, Eastern China [PDF]

open access: yesBMC Health Services Research, 2019
Background The shortage of benzathine penicillin G (BPG) worldwide presents a major challenge in the treatment of syphilis. Its availability for syphilis treatment has not been adequately evaluated in China.
Xinlong Chen   +4 more
doaj   +2 more sources

Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease [PDF]

open access: yesIDCases, 2016
A 7-year old boy developed myositis secondary to intramuscular injection of benzathine penicillin-G in the context of secondary prophylaxis for rheumatic heart disease.
Joshua R. Francis   +4 more
doaj   +2 more sources

Benzathine Penicillin G Shortage and Secondary Syphilis. [PDF]

open access: yesCureus
Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. This disease is characterized by four different stages, each presenting with a variety of manifestations or asymptomatic disease. These stages can be further broken down into early-stage syphilis, which includes primary and secondary syphilis, and late-stage ...
Snider W, Depew I, Cook S, Roth D.
europepmc   +3 more sources

Treatment of Syphilis in Pregnancy and Congenital Syphilis: Current Evidence, Challenges, and Future Directions [PDF]

open access: yesAntibiotics
Syphilis remains a global public health concern, with maternal infection posing a substantial risk for congenital syphilis, a preventable condition associated with severe morbidity and mortality.
Serena Salomè, Chryssoula Tzialla
doaj   +2 more sources

Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland [PDF]

open access: yesFrontiers in Pharmacology, 2017
Benzathine Penicillin G (BPG) is commonly used for treatment of penicillin-susceptible infections and secondary prevention of rheumatic fever. Death following administration of BPG is extremely rare—only a handful of cases have been described in the ...
Matitiahu Berkovitch   +15 more
doaj   +2 more sources

Barriers and facilitators of benzathine penicillin G adherence among rheumatic heart disease patients: a mixed methods systematic review using the COM-B (capability, opportunity, and motivation for behavior) model [PDF]

open access: yesSystematic Reviews
Background Benzathine penicillin G (BPG) is a proven preventive agent for preventing the progression of rheumatic heart disease (RHD) and is recognized as a standard of care. However, ensuring adherence to BPG remains a global challenge. The objective of
Habtamu Abera Areri   +2 more
doaj   +2 more sources

Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis. [PDF]

open access: yesPLoS ONE
BackgroundFear of severe adverse reaction (SAR) and reluctance of health care providers to administer intramuscular injections are major contributing factors to poor adherence of benzathine penicillin G (BPG) in the management of rheumatic heart disease (
Eshetie Melese Birru   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy